Literature DB >> 6148919

Removal of gastrinomas for control of Zollinger-Ellison syndrome.

J W Harmon, J A Norton, M J Collin, A G Krudy, T H Shawker, J L Doppman, J d'Avis, R T Jensen.   

Abstract

There are two distinct problems in patients with Zollinger-Ellison Syndrome (ZES): peptic ulcer diathesis and malignant tumors. Antisecretory drugs have allowed us to control the ulcer symptoms and acid output in 45 patients with ZES. We report here the initial seven patients selected for surgical exploration with the goal of removing their gastrinomas. Prior to surgery, an extensive and rigorous protocol to localize the gastrinoma was carried out, including hypotonic duodenography, abdominal ultrasonography, selective arteriography, portal vein sampling for gastrin, and computerized tomography. With this protocol of radiographic localization, gastrinomas were found in two of the seven cases and the syndrome was "cured" in three of the seven patients. The results also demonstrate that preoperative localization is not a substitute for careful surgical exploration as tumors were found in two patients in whom localization failed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6148919      PMCID: PMC1250501          DOI: 10.1097/00000658-198410000-00002

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  21 in total

1.  Excisional therapy for ulcerogenic tumors of the duodenum: long-term results.

Authors:  H A Oberhelman
Journal:  Arch Surg       Date:  1972-04

2.  Extrapancreatic, extraintestinal gastrinoma: effective treatment by surgery.

Authors:  M M Wolfe; R W Alexander; J E McGuigan
Journal:  N Engl J Med       Date:  1982-06-24       Impact factor: 91.245

3.  Comparative study of the value of the calcium, secretin, and meal stimulated increase in serum gastrin to the diagnosis of the Zollinger-Ellison syndrome.

Authors:  C G Lamers; J H Van Tongeren
Journal:  Gut       Date:  1977-02       Impact factor: 23.059

4.  Resection of gastrinoma in the Zollinger-Ellison syndrome.

Authors:  R F Barreras; E Mack; T Goodfriend; M Damm
Journal:  Gastroenterology       Date:  1982-05       Impact factor: 22.682

5.  Resection of gastrinomas.

Authors:  C W Deveney; K E Deveney; D Stark; A Moss; S Stein; L W Way
Journal:  Ann Surg       Date:  1983-10       Impact factor: 12.969

6.  Detection of pancreatic tumors by ultrasound during surgery.

Authors:  B Sigel; J C Coelho; L M Nyhus; J M Velasco; P E Donahue; D K Wood; D G Spigos
Journal:  Arch Surg       Date:  1982-08

7.  Observations on the postoperative tumor growth behavior of certain islet cell tumors.

Authors:  R M Zollinger; E W Martin; L C Carey; J Sparks; J P Minton
Journal:  Ann Surg       Date:  1976-10       Impact factor: 12.969

8.  Comparison of ranitidine and cimetidine in the treatment of gastric hypersecretion.

Authors:  M J Collen; J M Howard; K E McArthur; J P Raufman; M J Cornelius; C A Ciarleglio; J D Gardner; R T Jensen
Journal:  Ann Intern Med       Date:  1984-01       Impact factor: 25.391

9.  Effect of vagotomy in Zollinger-Ellison syndrome.

Authors:  C T Richardson; M Feldman; R N McClelland; R M Dickerman; D Kumpuris; J S Fordtran
Journal:  Gastroenterology       Date:  1979-10       Impact factor: 22.682

10.  Ultrasonic investigation of pancreatic islet cell tumors.

Authors:  T H Shawker; J L Doppman; N R Dunnick; D M McCarthy
Journal:  J Ultrasound Med       Date:  1982 Jun-Jul       Impact factor: 2.153

View more
  11 in total

Review 1.  Unresolved surgical issues in the management of patients with Zollinger-Ellison syndrome.

Authors:  J A Norton; R T Jensen
Journal:  World J Surg       Date:  1991 Jan-Feb       Impact factor: 3.352

2.  The use of intraoperative sonography in endocrine tumors of the pancreas.

Authors:  H J Klotter; K Rückert; F Kümmerle; M Rothmund
Journal:  World J Surg       Date:  1987-10       Impact factor: 3.352

3.  Current approach to the management of tumoral process in patients with gastrinoma.

Authors:  M Mignon; P Ruszniewski; S Haffar; D Rigaud; E Rene; S Bonfils
Journal:  World J Surg       Date:  1986-08       Impact factor: 3.352

4.  Prospective study of gastrinoma localization and resection in patients with Zollinger-Ellison syndrome.

Authors:  J A Norton; J L Doppman; M J Collen; J W Harmon; P N Maton; J D Gardner; R T Jensen
Journal:  Ann Surg       Date:  1986-10       Impact factor: 12.969

Review 5.  Pathologic aspects of gastrinomas in patients with Zollinger-Ellison syndrome with and without multiple endocrine neoplasia type I.

Authors:  M Pipeleers-Marichal; C Donow; P U Heitz; G Klöppel
Journal:  World J Surg       Date:  1993 Jul-Aug       Impact factor: 3.352

6.  Usefulness of selective arterial secretin injection test for localization of gastrinoma in the Zollinger-Ellison syndrome.

Authors:  M Imamura; K Takahashi; H Adachi; S Minematsu; Y Shimada; M Naito; T Suzuki; T Tobe; T Azuma
Journal:  Ann Surg       Date:  1987-03       Impact factor: 12.969

7.  Curative resection in Zollinger-Ellison syndrome. Results of a 10-year prospective study.

Authors:  J A Norton; J L Doppman; R T Jensen
Journal:  Ann Surg       Date:  1992-01       Impact factor: 12.969

8.  Outcome of lymph node involvement in patients with the Zollinger-Ellison syndrome.

Authors:  R Delcore; L Y Cheung; S R Friesen
Journal:  Ann Surg       Date:  1988-09       Impact factor: 12.969

9.  Microgastrinomas of the duodenum. A cause of failed operations for the Zollinger-Ellison syndrome.

Authors:  N W Thompson; A I Vinik; F E Eckhauser
Journal:  Ann Surg       Date:  1989-04       Impact factor: 12.969

10.  Aggressive resection of metastatic disease in selected patients with malignant gastrinoma.

Authors:  J A Norton; P H Sugarbaker; J L Doppman; R A Wesley; P N Maton; J D Gardner; R T Jensen
Journal:  Ann Surg       Date:  1986-04       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.